Evidence map›Paper›PMID 31406143›Full record

ArticleScientific reports2019

Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis.

Fatema Tuz Zahra, Md Sanaullah Sajib, Yusuke Ichiyama, Racheal Grace Akwii, Paul E Tullar, Christopher Cobos, Shelby A Minchew, Colleen L Doçi, Yi Zheng, Yoshiaki Kubota and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Inhibition ofInternational journal of molecular sciences · 2023
    Article
  11. Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles.The Journal of pharmacology and experimental therapeutics · 2023
    Article
  12. The matricellular protein CCN3 supports lung endothelial homeostasis and function.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  13. The Role of Hypoxia in Brain Tumor Immune Responses.Brain tumor research and treatment · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. WNK1 collaborates with TGF-β in endothelial cell junction turnover and angiogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Fatema Tuz ZahraDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA.
Md Sanaullah SajibDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA.
Yusuke IchiyamaDepartment of Anatomy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Racheal Grace AkwiiDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA.
Paul E TullarDepartment of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA.
Christopher CobosDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA.
Shelby A MinchewDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA.
Colleen L DoçiCollege of Arts and Sciences, Marian University Indianapolis, Indianapolis, Indiana, 46222, USA.
Yi ZhengCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, 45229, USA.
Yoshiaki KubotaDepartment of Anatomy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0001-6672-4122
J Silvio GutkindDepartment of Pharmacology, UCSD, San Diego, California, 92093, USA.
Constantinos M MikelisDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106, USA. constantinos.mikelis@ttuhsc.edu.
Texas Tech University · USCincinnati Children's Hospital Medical Center · USKeio University Hospital · JPMarian University - Indiana · USShiga University of Medical Science · JPUniversity of California San Diego · US

Funding

Novel Class of Chemotherapeutic Agents for Treatment of Metastatic Triple-negative Breast CancerR15CA231339 · NCI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GERMAN, NADEZHDA A, MIKELIS, CONSTANTINOS MARIOS · 2018 to 2018
$459k
NCI NIH HHS R15 CA231339
6 · The paper itself

Abstract

Imbalanced angiogenesis is a characteristic of several diseases. Rho GTPases regulate multiple cellular processes, such as cytoskeletal rearrangement, cell movement, microtubule dynamics, signal transduction and gene expression. Among the Rho GTPases, RhoA, Rac1 and Cdc42 are best characterized. The role of endothelial Rac1 and Cdc42 in embryonic development and retinal angiogenesis has been studied, however the role of endothelial RhoA is yet to be explored. Here, we aimed to identify the role of endothelial RhoA in endothelial cell functions, in embryonic and retinal development and explored compensatory mechanisms. In vitro, RhoA is involved in cell proliferation, migration and tube formation, triggered by the angiogenesis inducers Vascular Endothelial Growth Factor (VEGF) and Sphingosine-1 Phosphate (S1P). In vivo, through constitutive and inducible endothelial RhoA deficiency we tested the role of endothelial RhoA in embryonic development and retinal angiogenesis. Constitutive endothelial RhoA deficiency, although decreased survival, was not detrimental for embryonic development, while inducible endothelial RhoA deficiency presented only mild deficiencies in the retina. The redundant role of RhoA in vivo can be attributed to potential differences in the signaling cues regulating angiogenesis in physiological versus pathological conditions and to the alternative compensatory mechanisms that may be present in the in vivo setting.

Indexed as

Neovascularization, PhysiologicAnimalsCell LineCell MovementCell ProliferationEmbryo, MammalianEmbryonic DevelopmentEndothelium, VascularFemaleHumansHuman Umbilical Vein Endothelial CellsLysophospholipidsMaleMice, TransgenicRetinal VesselsrhoA GTP-Binding ProteinLysophospholipidsrhoA GTP-Binding ProteinRHOA protein, humanRhoA protein, mouseSphingosinesphingosine 1-phosphateVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseVEGFA protein, human

Identifiers

PMID31406143
PMCPMC6690958
OpenAlexW2967466857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.